iPSC-based in vitro model of Parkinson's disease caused by OPA1 mutations

被引：0
|
作者：
Iannielli, A. [1 ]
Folladori, L. [1 ]
Cancellieri, C. [1 ]
Morabito, G. [1 ]
Massimino, L. [1 ]
Indrigo, M. [1 ]
Segnali, A. [3 ]
Maresca, A. [4 ,5 ]
Caporali, L. [4 ,5 ]
Carelli, V. [4 ,5 ]
Tiranti, V. [3 ]
Broccoli, V. [1 ,2 ]
机构：
[1] Ist Sci San Raffaele, Div Neurosci, Stem Cell & Neurogenesis Unit, Milan, Italy
[2] CNR, Natl Res Council, Inst Neurosci, Milan, Italy
[3] IRCCS Fdn Neurol Inst C Besta, Div Mol Neurogenet, Milan, Italy
[4] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy
[5] Univ Bologna, Dept Biomed & Neuromotor Sci, Neurol Unit, Bologna, Italy
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P097
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [41] A murine model of transitory optic neuropathy based on small interference RNA-induced OPA1 silencing in vivo (gene mutation associated with Kjer's disease)
    Depeyre, C.
    Chen-Kuo-Chang, M.
    Payet, O.
    Cornille, K.
    Muller, A.
    Lenaers, G.
    Hamel, C.
    Arne, J. L.
    Arndt, C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2006, 29 (08): : 875 - 880
  • [42] G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients
    Deng, H
    Le, WD
    Zhang, X
    Pan, TH
    Jankovic, J
    ACTA NEUROLOGICA SCANDINAVICA, 2005, 111 (06): : 351 - 352
  • [43] Stem Cells as In Vitro Model of Parkinson's Disease
    Martinez-Morales, Patricia L.
    Liste, Isabel
    STEM CELLS INTERNATIONAL, 2012, 2012
  • [44] PRELIMINARY DEVELOPMENT OF AN IN VITRO 3D IPSC-BASED LIVER MODEL TO EXPLOIT AN INNOVATIVE LIVER-ON-A-CHIP DEVICE
    Fanizza, Francesca
    Bonanome, Chiara
    Forloni, Gianluigi
    Giordano, Carmen
    Albani, Diego
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 645 - 646
  • [45] Gemini/DOPE/PEGylated-based Lipoplexes for the efficient expression of OPA1 mitochondrial protein in in vitro and in vivo experiments
    Munoz-Ubeda, M.
    Semenzato, M.
    Romero, A. Franco
    Junquera, E.
    Aicart, E.
    Scorrano, L.
    Lopez-Montero, I.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2019, 48 : S92 - S92
  • [46] A human iPSC model of Parkinson's disease reveals altered sensitivity to a metal neurotoxicant
    Tidball, A. M.
    Aboud, A. A.
    Neely, D.
    Hong, C. C.
    Hedera, P.
    Ess, K. C.
    Bowman, A. B.
    MOVEMENT DISORDERS, 2011, 26 : S186 - S186
  • [47] iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's Disease
    Badanjak, Katja
    Mulica, Patrycja
    Smajic, Semra
    Delcambre, Sylvie
    Tranchevent, Leon-Charles
    Diederich, Nico
    Rauen, Thomas
    Schwamborn, Jens C.
    Glaab, Enrico
    Cowley, Sally A.
    Antony, Paul M. A.
    Pereira, Sandro L.
    Venegas, Carmen
    Gruenewald, Anne
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [48] Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson's disease
    Mubariz, Fahad
    Saadin, Afsoon
    Lingenfelter, Nicholas
    Sarkar, Chinmoy
    Banerjee, Aditi
    Lipinski, Marta M.
    Awad, Ola
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [49] Late onset sporadic Parkinson's disease caused by PINK1 mutations:: Clinical and functional study
    Gelmetti, Vania
    Ferraris, Alessandro
    Brusa, Livia
    Romano, Francesca
    Lombardi, Federica
    Barzaghi, Chiara
    Stanzione, Paolo
    Garavaglia, Barbara
    Dallapiccola, Bruno
    Valente, Enza Maria
    MOVEMENT DISORDERS, 2008, 23 (06) : 881 - 885
  • [50] Genetic analysis of G309D and W437OPA mutations of PINK1 in Parkinson's disease patients
    Hao, D
    Le, WD
    Zhang, X
    Pan, TH
    Jankovic, J
    NEUROLOGY, 2005, 64 (06) : A90 - A90
12345